Key facts
| Price (PPV) | 60.60 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | losartanhydrochlorothiazide |
| Class | Agents acting on the renin-angiotensin system |
| ATC code | C09DA01 |
| Manufacturer | AFRIC-PHAR |
| Presentation | Boite de 14 |
| Nature | Médicament |
| Hospital price | 37.90 MAD |
| Data collected on | 9/8/2026 |
Indications
Traitement de l’hypertension artérielle essentielle chez les patients dont la pression artérielle n’est pas suffisamment contrôlée par le losartan ou l’hydrochlorothiazide en monothérapie.
Find an open pharmacy
On-call pharmacies near you
Same-strength alternatives — cheapest first
9 other products contain the same active substance as Co-Tanzaar 50 mg / 12.5 mg (Losartan | Hydrochlorothiazide), at the same strength and in the same dosage form. The prices below are per pack: compare pack sizes before comparing prices.
Same pack size
| Product | Manufacturer | Pack | PPV | Unit price | Difference |
|---|---|---|---|---|---|
| Bi-Hyplos 50 mg / 12.5 mg | SPIMACO | Boite de 14 | 60.60 MAD | 4.33 / unit | — |
Other pack sizes
| Product | Manufacturer | Pack | PPV | Unit price |
|---|---|---|---|---|
| Ancine Plus 50 mg / 12.5 mg | NOVOPHARMA | Boite de 30 | 64.20 MAD | 2.14 / unit |
| Bi-Hyplos 50 mg / 12.5 mg | SPIMACO | Boite de 28 | 90 MAD | 3.21 / unit |
| Co-Rosar 50 mg / 12.5 mg | PHARMIS | Boite de 28 | 101 MAD | 3.61 / unit |
| Co Medzar 50 mg / 12.5 mg | POLYMEDIC | Boite de 30 | 106.70 MAD | 3.56 / unit |
| Co-Anginib 50 mg / 12.5 mg | PHI | Boite de 30 | 114.30 MAD | 3.81 / unit |
| Diprezar 50 mg / 12.5 mg | BOTTU S.A. | Boîte de 30 | 114.30 MAD | 3.81 / unit |
| Losartan / Hydrochlorothiazide GT 50 mg / 12.5 mg | ATLAS PHARM | Boite de 30 | 114.30 MAD | 3.81 / unit |
Substituting a generic is the pharmacist's decision; for medicines listed in schedules A, B and C it still requires a prescription. Public sale prices published by the Directorate of Medicines and Pharmacy, recorded on 9/8/2026.
About Co-Tanzaar 50 mg / 12.5 mg
Co-Tanzaar 50 mg / 12.5 mg belongs to the agents acting on the renin-angiotensin system therapeutic class. In Morocco, this drug is marketed by AFRIC-PHAR and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Co-Tanzaar 50 mg / 12.5 mg, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Co-Tanzaar 50 mg / 12.5 mg
Answers to common questions from Moroccan patients about this drug.